Related Experiment Video
Updated: Aug 16, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk
Antje K Rottner1, Yingying Ye2, Elena Navarro-Guerrero3
1Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Abstract:
Identification of the genes and processes mediating genetic association signals for complex diseases represents a major challenge. As many of the genetic signals for type 2 diabetes (T2D) exert their effects through pancreatic islet-cell dysfunction, we performed a genome-wide pooled CRISPR loss-of-function screen in a human pancreatic beta cell line. We assessed the regulation of insulin content as a disease-relevant readout of beta cell function and identified 580 genes influencing this phenotype. Integration with genetic and genomic data provided experimental support for 20 candidate T2D effector transcripts including the autophagy receptor CALCOCO2. Loss of CALCOCO2 was associated with distorted mitochondria, less proinsulin-containing immature granules and accumulation of autophagosomes upon inhibition of late-stage autophagy. Carriers of T2D-associated variants at the CALCOCO2 locus further displayed altered insulin secretion. Our study highlights how cellular screens can augment existing multi-omic efforts to support mechanistic understanding and provide evidence for causal effects at genome-wide association studies loci.
Insights
This study used CRISPR screening in beta cells to find genes affecting type 2 diabetes (T2D). Researchers identified CALCOCO2 as a key gene, linking its function to insulin secretion and T2D risk.
Area of Science:
- Genetics
- Cell Biology
- Metabolic Diseases
Background:
- Identifying causal genes for complex diseases like type 2 diabetes (T2D) is challenging.
- Many T2D genetic signals impact pancreatic beta cell function.
Purpose of the Study:
- To identify genes and pathways regulating pancreatic beta cell function relevant to T2D.
- To experimentally validate candidate T2D genes using a functional genomics approach.
Main Methods:
- Genome-wide pooled CRISPR loss-of-function screen in a human pancreatic beta cell line.
- Assessed regulation of insulin content as a readout of beta cell function.
- Integrated screening data with genetic and genomic datasets.
Main Results:
- Identified 580 genes influencing insulin content in beta cells.
- Provided experimental support for 20 candidate T2D effector transcripts.
- Demonstrated that loss of CALCOCO2 impairs beta cell function, affecting mitochondria, insulin granules, and autophagy, and is linked to T2D variants and altered insulin secretion.
Conclusions:
- Cellular screens can enhance multi-omic studies for understanding complex disease mechanisms.
- Provided evidence for causal roles of specific genes, including CALCOCO2, at genome-wide association study loci for T2D.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Cell Specific Gene Expression
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes Mellitus: Type 2 and Gestational
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

